Pérez-Belmonte, Luis M.Moreno-Santos, InmaculadaGómez Doblas, Juan JoséGarcía-Pinilla, José ManuelMorcillo-Hidalgo, LuisGarrido-Sánchez, LourdesSantiago-Fernández, ConcepciónCrespo-Leiro, María GenerosaCarrasco-Chinchilla, FernandoSánchez, Pedro LTeresa Galván, Eduardo deJiménez-Navarro, Manuel Francisco2017-08-282017-08-282017-07-20Pérez-Belmonte LM, Moreno-Santos I, Gómez-Doblas JJ, et al. Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure. Int J Med Sci [Internet]. 2017 Jul 20 [acceso 2017 Ago 28]; 14(9): 891-895. Disponible en: http://www.medsci.org/v14p0891.htm1449-1907http://hdl.handle.net/2183/19360[Abstract] Epicardial adipose tissue has been proposed to participate in the pathogenesis of heart failure. The aim of our study was to assess the expression of thermogenic genes (Uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), and PR-domain-missing 16 (PRDM16) in epicardial adipose tissue in patients with heart failure, stablishing the difference according to left ventricular ejection fraction (reduced or preserved). Among the 75 patients in our study, 42.7% (n=32) had reduced left ventricular ejection fraction. UCP1, PGC1α and PRDM16 mRNA in EAT were significantly lower in patients with reduced left ventricular ejection fraction. Multiple regression analysis showed that age, male gender, body max index, presence of obesity, type-2-diabetes mellitus, hypertension and coronary artery disease and left ventricular ejection fraction were associated with the expression levels of UCP1, PGC1α and PRDM16 mRNA. Thermogenic genes expressions in epicardial adipose tissue (UCP1: OR 0.617, 95%CI 0.103-0.989, p=0.042; PGC1α: OR 0.416, 95%CI 0.171-0.912, p=0.031; PRDM16: OR 0.643, 95%CI 0.116-0.997, p=0.044) were showed as protective factors against the presence of heart failure with reduced left ventricular ejection fraction, and age (OR 1.643, 95%CI 1.001-3.143, p=0.026), presence of coronary artery disease (OR 6.743, 95%CI 1.932-15.301, p<0.001) and type-2-diabetes mellitus (OR 4.031, 95%CI 1.099-7.231, p<0.001) were associated as risk factors. The adequate expression of thermogenic genes has been shown as possible protective factors against heart failure with reduced ejection fraction, suggesting that a loss of functional epicardial adipose tissue brown-like features would participate in a deleterious manner on heart metabolism. Thermogenic genes could represent a future novel therapeutic target in heart failure.engAtribución 3.0 Españahttp://creativecommons.org/licenses/by/3.0/es/Epicardial adipose tissueHeart failureLeft ventricular ejection fractionThermogenic genesjournal articleopen access